
Last month, Serum had rejected charges that a 40-year-old man who took part in the 'Covishield' vaccine trial in Chennai had levelled against the company, alleging serious side effects, including a virtual neurological breakdown and impairment of cognitive functions.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2WrraDI
via
IFTTT
0 comments:
Post a Comment